Our Dermal Delivery technology client from Australia has given another assignment for finding a right partner for their High End Cosmetics range of pr...
Published : 15 Aug 2012
Read MoreThe scientific company using nanotechnology for various applications has entrusted Aagami again with a Net Present Value modeling for their Solar ener...
Published : 13 Jul 2012
Read MoreOur Belgian client, a specialist in manufacturing Peptides gets another customer in India for one of their APIs. This is their 6th customer, a on...
Published : 29 Jun 2012
Read MoreAagami's CEO Dinesh Jain and Head BD Ed Steinhardt attended the Biotech Industry Organization (BIO) 2012 annual convention in Boston.Both were quite b...
Published : 05 Jun 2012
Read MoreToday our Melbourne based publicly listed client received their second success in Out-licensing their drug delivery technology for 3 anti-aging formul...
Published : 04 Apr 2012
Read MoreA nanotechnology based Diagnostic technology platform company, which has evolved from top notch Brazilian university, today retained Aagami for its li...
Published : 15 Feb 2012
Read MoreAagami has been contracted to work for a biotechnology company based in Barcelona to find co-development, licensing and investment partners from India...
Published : 05 Feb 2012
Read MoreA Oregon drug development company, with innovative technology licensed from Portland State University, is developing 3 projects pipeline two antimalar...
Published : 16 Jan 2012
Read MoreIn January 2012, Dinesh Jain CEO of Aagami and Ed Steinhardt Head BD will go to San Francisco for attending J P Morgan Healthcare conference and Biote...
Published : 27 Dec 2011
Read MoreAagami client AdvanGene today signed the distribution agreement with Gangwal Chemicals Pvt. Ltd. of Mumbai India.AdvanGene is Chicago area based...
Published : 12 Dec 2011
Read More